key: cord-0992951-zvysd621
authors: Shaver, Julia
title: The State of Telehealth Before and After the COVID-19 Pandemic
date: 2022-04-25
journal: Prim Care
DOI: 10.1016/j.pop.2022.04.002
sha: ba89d22634bded92845e62adca34930701d2ae94
doc_id: 992951
cord_uid: zvysd621

Telemedicine has been under-utilized and not well studied until the COVID-19 pandemic. At the onset of the pandemic, in-person care quickly transitioned to remote consultation, facilitated by legislation that waived regulations and increased payment parity. A comprehensive look at our collective experience with telemedicine as published in literature suggests it has many advantages for patients and healthcare providers, it can often result in outcomes similar to in-person care, and it may have cost-saving implications. We must better define what conditions are best suited to telemedicine and how to dispense that care remotely, what communication techniques facilitate good telemedicine rapport, how to help patients more equitably access telemedicine, and how to best educate the future healthcare workforce. (100 words)

The "house call" from doctors is surging in the United Statesand instead of ringing the doorbell, your doctor is pinging your Smartphone. Telemedicine, or receiving one's medical care remotely via synchronous, asynchronous, or store-and-forward technology, had been on a steady rise for the last decade but the overall growth had remained slow until March 6, 2020. In response to the Sars-Cov2 pandemic crisis, the United States Congress toppled a multitude of telemedicine regulations and telemedicine expanded rapidly. Although the acute pandemic crisis may be entering its long tail, telemedicine will remain a permanent fixture in routine American healthcare. How will this serve us as practitioners and patrons of medicine? The experiences of the last several years can help us forge our path forward into a future with virtual healthcare.

The definitions of these two terms depend upon who you ask and what you read, as there are currently over one hundred different peer reviewed definitions. 1 A general consensus shared by most is that telemedicine refers to providing clinical services (either in real-time or asynchronously) between patient-clinician and/or clinician-clinician when the two parties are physically remote from one another using some form of information-communication technology.

The term telehealth is a larger umbrella term encompassing other remote health related services such as administration, continuing medical education, and/or provider training.

Prior to March 2020, telemedicine use in the US was on a steadily rising trajectory but its absolute integration remained low and the logistics were complex. 2, 3 Patients and providers who desired to use it navigated inconsistent and often inadequate reimbursement for services, restrictions on where each party must be located and what sort of technology interface they must use, and privacy regulations that necessitated costly investments in secure telecommunication technology. Providers were (and often still are even in a post-pandemic landscape) limited from treating traveling patients by interstate licensing restrictions, and juggled miscellaneous rules about prescriptions, types of visits, and types of patients that were or were not acceptable for telemedicine. 4 Despite these hurdles, 76% of US hospital systems employed some form of telemedicine as of 2018 with radiology, psychiatry, and cardiology noted as the highest users of the modality. 5 Systems factors such as technology capability of the electronic medical record (EMR) and other characteristics driven by reimbursement policies (such as rural location) influenced which hospitals or clinics were more likely to offer telehealth, 6, 7 further limiting which patients even had the option of using this service. Of the patients who were able to access telemedicine prior to March 2020, their overall impressions were positive. [8] [9] [10] [11] [12] [13] In a systematic review on the topic, the most frequently cited factors associated with patient telehealth satisfaction included improved outcomes (defined a variety of ways due to heterogeneity of the 44 included studies), preferred modality over face-toface visits, ease of use, low cost, improved communication, and elimination of travel time. 9 Patients also expressed some concerns about telemedicine such as data security. 14 The telemedicine appointments assessed in these studies were almost entirely video-conferencing rather than telephone-only due to reimbursement restrictions on the latter.

Clinicians had a more variable opinion of telemedicine, perhaps driven by inexperience as most were not using it prior to the pandemic, and even those who did use it still conducted the majority of their visits in person. About half of clinicians surveyed in one setting (respondents largely consisting of psychiatry providers) who were actively using both telehealth and office visits in their practices were concerned that the personal connection through telehealth was inferior to office visits. 11 Approximately one-third of those clinicians also stated that the overall quality of the visit was better in person. Family medicine providers (N=1,630) surveyed about the reasons behind their non-use of telehealth were more likely than current users to feel it was an inefficient use of their time, and express concerns about the overall quality of care and the liability potential. Non-users were also more likely to cite lack of training, equipment costs, liability concerns, and inadequate reimbursement as barriers to telehealth. 15

Use J o u r n a l P r e -p r o o f In response, practices greatly expanded telemedicine services during the long months of shelterin-place and recurrent surges of COVID-19 infections, and patient use of telehealth services blossomed. A national study including 36 million working-age individuals with private insurance claims data showed that telemedicine encounters increased 766% in the first three months of the pandemic, from 0.3% of all interactions in March-June 2019, to 23.6% of all interactions in same period. 16 This is in line with research by the Doximity online medical networking service, which counts 1.8 million physicians (about 80% of the US physician workforce) amongst its membership, estimating with private claims data that approximately 20% of all US healthcare visits in 2020 were conducted by telemedicine. 17 However, even as telemedicine skyrocketed, medical care in general across the United States showed a sharp decline that could not be made whole despite best efforts. One estimate using claims data from 16.7 million Medicare Advantage and commercial insurance patients estimated that total outpatient visits plummeted by 30% of usual volume between January and June 2020, and that telemedicine only compensated for about two-thirds of this loss. 18 

Who is using telemedicine now?

Although disappearing regulations have somewhat leveled the playing field for all to participate, there are still various factors that predict which physicians and which patients are more likely to engage in telemedicine. What we know about physicians accessing telemedicine comes from studies of large academic practices, claims data from commercial insurance, and research from Doximity.

According to available data, the number of physicians reporting telemedicine as an active skill has doubled as of 2020, from 20% to just under 40% of the Doximity survey. 17 A physician most likely to be practicing telehealth today treats patients who have chronic diseases, such as in endocrinology, gastroenterology, rheumatology, nephrology, cardiology, psychiatry, while physicians in dermatology, orthopedic surgery, or optometry are least likely to report J o u r n a l P r e -p r o o f telemedicine use (note: these references did not distinguish between subspecialists who treat chronic disease and primary care physicians who may treat the same conditions). 17, 18, 21 Telemedicine practitioners tend to identify as female more often than male and are in the middleage range of practice between 40 and 60 years of age. 17 They live predominantly in large metropolitan areas or on the East Coast. 17, 18 The clinician demographics are likely influenced by the inherent demographics of the high-telemedicine specialties.

As telehealth rapidly evolves, it is important to note what has changed (and what has not) now that insurance type, physical location, and technology platform should present fewer barriers for all to use telemedicine. Historically, it has been challenging to describe the typical "telemedicine user", since telemedicine use was such a small proportion of care prior to the pandemic. What has been reported about the demographics of telemedicine users before 2020 reflects what would be expected of those select patients that that either were granted access (e.g. large academic centers, Veterans Administration health system, integrated health systems) or purchased access (e.g. through direct-to-consumer telemedicine services). In contrast, some patients who would be expected to frequently use telemedicine (including those who live far away from in-person care such as large areas in the middle of the United States) were often effectively excluded due to lower rates of household internet access. Others who suffered from the digital divide included households of lower socioeconomic status and patients with disabilities. 22 With the advent of the pandemic in 2020, reimbursable telemedicine services expanded to include telephone-only visits and removed geographic barriers and platform restrictions.

Interestingly, this has not addressed the inequities in telemedicine use as much as one might predict. Studies inclusive of March-August 2020 which examined demographics of new telemedicine users show a surprisingly similar picture to the pre-pandemic period: patients who J o u r n a l P r e -p r o o f utilize telemedicine still tend to be White, younger, wealthier, and more urban-dwelling than non-telemedicine using peers. 16, [23] [24] [25] [26] This demographic discrepancy becomes even more apparent when examining video telemedicine users compared to telephone (audio-only) users. 23, 24, 26 Although this picture of the typical telemedicine user may reflect the larger troubling patterns of inequitable access in general to medical care in our country, this data should still guide us as we move into a more telemedicine-dependent future. Our most vulnerable, marginalized, and chronically ill patients will need additional attention and funding dollars to understand all their barriers (digital and otherwise) to this type of care that we hope could address their care gaps, and to prevent telemedicine from becoming yet another wedge to widen medical disparities in our country.

Despite the observed differences in utilization, telemedicine visits did globally increase for all types of patients compared to rates in 2019 and prior, especially among those with chronic illnesses. 17 Perceptions of telemedicine care from this much larger sample of users continue to be overall positive whether they are new to telemedicine or experienced. One survey of 800 patients at Penn Medicine in the first half of 2020 reported that 67% of respondents considered their video or telephone visit "as good or better" than a standard in-person visit. 27 A similar survey of 1,011 University of Michigan Medicine patients in early 2020 showed similar degrees of high satisfaction between first-time users and repeat patient users of telemedicine. 28 Additionally, although telemedicine use varies significantly based on certain demographics (as described above) due to either preference or barriers, the those who use it across different demographics seem to have a similar experience. A nationally representative sample of US households (N=3454) surveyed on telemedicine use during the pandemic affirmed that J o u r n a l P r e -p r o o f telemedicine use differed significantly based on race, household income, insurance status, and presence of high-speed internet (in keeping with the literature cited above), but that those who did use telemedicine even in lower-income households, non-White households, etc. seemed equally as satisfied with their experience. 29 What do we know about conditions that are evaluated by telemedicine?

When reviewing literature to date, telemedicine is often evaluated by examining patient acceptance of care using technology, patient and clinician satisfaction with the visit, and patient perception of care they received. Studies examining patient-oriented health outcomes or economic impact on individuals and systems are less common and are needed to delineate how telemedicine can be best employed for future medical care.

Prior to the COVID-19 pandemic, research on telemedicine healthcare outcomes had some inherent challenges. Patients utilizing telemedicine were a self-selected audience with the inherent differences that accompany this, and telemedicine is a broad category that encompasses many different intervention types ranging from simple telephone encounters to highly intensive encounters involving facilitators or digital exam equipment such as stethoscopes or otoscopes able to transmit audio-visual information to a remote provider. Likewise, it is challenging to compare outcomes between telemedicine and face-to-face care in a pre-pandemic world where clinicians might prioritize in-person encounters for more high-risk or medically complex individuals when there is no limitation or disincentive for doing so.

Despite these challenges, there is now more literature to support telemedicine as a viable alternative to in-person care in certain situations. One of the more comprehensive looks at this topic was a systematic review of telemedicine practice in primary care prior to the pandemic, J o u r n a l P r e -p r o o f including 81 studies conducted both domestically and abroad. 30 The results from this study have been supplemented by other publications conducted during the pandemic with general conclusions about patient outcomes for different categories of care as summarized below.

Telemedicine has been studied in various acute conditions as compared to usual care including uncomplicated cystitis, upper respiratory tract infections (URI), pharyngitis, and low back pain.

Results of these studies are heterogenous. Some suggest that telemedicine care for conditions such as URI and low back pain can result in similar or improved clinical outcomes for patients, with "clinical outcomes" usually defined narrowly as a single categorical item (such as appropriate vs inappropriate use of antibiotics for a given diagnosis). In a nurse-administered telephone or a web-based protocol for URI and sinusitis treatment, overall antibiotic administration with telemedicine for viral URI was less than usual care, and first-line antibiotics were more often prescribed for cases of sinusitis meeting clinical criteria. 31, 32 In an evaluation of care administered by Teladoc, a direct-to-consumer telemedicine consultation service, telemedicine consultations did not order imaging for low back pain (appropriately so) at about the same rate as in-person evaluations. 33 Other studies in direct-to-consumer telemedicine differ, suggesting that patients who received telemedicine may be more likely to receive inappropriate antibiotics than when seen in face-toface care [33] [34] [35] and are less likely to receive an appropriate rapid strep test for evaluation of pharyngitis. 33 The variations in medication use and diagnostic testing seen in these studies may be explained by the context of a direct-to-consumer telemedicine encounter. The typical model for direct-to-consumer telemedicine is a single encounter between a clinician and patient who have no preceding relationship, and the clinician is often limited by lack of on-site testing, no J o u r n a l P r e -p r o o f means to bring patient in for a face-to-face examination, and little way to ensure the patient will access follow up care if they get worse. Telemedicine outcomes may look different when delivered within a context where physicians and patients know one another, a consistent medical record is available, on-site testing may be achievable, and there is more readily accessible follow up care.. An observational study in this type of setting (a large integrated health system) analyzed over 1 million visitstelephone, video, and office visitsfor any type of initial concern excluding routine physical exam during a 2-year period. Patients initiated scheduling of the visit modality themselves via a web-based scheduling portal and were not directed into a particular visit type based on their presenting complaint. The authors found that rates of overall prescribing of medication or imaging (across all diagnoses as well as a sub-analysis of visits only for URI symptoms) were actually lower for telemedicine (telephone or video) as opposed to inperson care, and that the need for ED or hospital visit within 7 days following the index visit did not differ between telemedicine and in-person. 36 This suggests that clinicians using telemedicine may be less likely to over-prescribe or over-utilize testing as a precautionary measure when they have some prior knowledge of the patient and when they feel confident that follow up care is available should things get worse.

This study also demonstrates that when examined in a very large sample and over a broad array of diagnoses, assessment and treatment via telemedicine seems no more likely to result in acute decompensation requiring emergency room services or hospitalization than traditional in-person care. Interestingly, this holds true in a setting when patients are free to choose the type of visit that best fits their needs, rather than being directed to a particular visit type based on chief complaint. However, emergency and hospital care is an uncommon outcome to begin with; in this study, overall rates of ER visits within a week of index visits were approximately 1% across J o u r n a l P r e -p r o o f all visit types, and hospitalizations less than 0.5%. Future studies may do well to see if this conclusion holds true when telemedicine care is used for specific diagnoses (dizziness, abdominal pain, dyspnea) that may be more challenging to assess, or for different types of telemedicine users that may have communication barriers.

For acute skin concerns, tele-dermatology is already used in multiple countries for routine dermatologic management, to consult on patients in remote locales, or for medical support in nursing homes or home care settings. 37 However, most studies to this point have not examined a specific comparison with usual (in-person) consultation. Tele-dermatology may serve an intuitive role as a follow-up method once a diagnosis has been established, to triage whether an in-person consultation is needed, or to guide primary physicians on the best next steps in management for routine conditions.

Telemedicine has been studied for many chronic conditions such as asthma, COPD, depression, diabetes, hypertension, hyperlipidemia, and heart failure. Some of the most robust evidence for improved patient outcomes with telemedicine care comes from pharmacist-based telemedicine interventions. A systematic review of 34 studies looking at chronic disease management using pharmacist-delivered care protocols examined outcomes for fourteen different conditions (hypertension, diabetes, anticoagulation, depression, hyperlipidemia, asthma, heart failure, HIV, post-traumatic stress disorder, chronic kidney disease, stroke, COPD, and smoking cessation). 38 The authors noted the heterogeneity of studies and for this reason did not perform a data synthesis to quantify collective results and instead performed a narrative review. Most included studies (N=25) examined telephone-only interventions as opposed to more technology-intensive ones, and studies were included in the final review if they utilized a comparison (i.e. face-to-J o u r n a l P r e -p r o o f face, usual care, or no intervention) and if they evaluated as outcomes either chronic disease management (i.e. achievement of lab values specific to therapeutic goals), patient selfmanagement (i.e. self-monitoring blood pressure or demonstration of inhaler use), or adherence (i.e. patient self-report or pharmacy records showing medication fills). Results showed good success for telemedicine interventions, with 23 out of 34 studies logging positive improvements in disease management, self-management, or adherence measures. Another 10 studies reported neutral outcomes (non-inferior to the comparison), and only one study concluded any sort of negative outcome for the telemedicine group. A scheduled model of caredescribed as pharmacists delivering telemedicine interventions to patients at pre-determined timeswas the most common and the most successful delivery system for improved outcomes as opposed to a responsive/reactive model (pharmacist reaching out to patient when being prompted to do so by a health system alert). Similar benefits of pharmacist led virtual care have been documented as health systems rapidly transitioned chronic disease care to virtual visits during the pandemic. 39 One notable aspect of this systemic review is the increased success of scheduled telemedicine care as opposed to a more responsive/reactive model, affirming that a high degree of reinforcement and support is beneficial for chronic disease management in general whether inperson or otherwise. Shifting some of this care to telemedicine could conceivably lower overall system costs through reduced overhead and possibly improved patient outcomes (if evidence cited above proves accurate) but would likely require up-front investment in clinicians or other personnel to support the consistent, high-frequency visits. The overall impact on physician and practice revenue is also unclear as reimbursement for telemedicine may become less favorable when the pandemic wanes.

Other small studies show some benefit of telemedicine for other chronic conditions. One study demonstrates that telemedicine intervention delivered over an extended period (ie 24 months) can be as successful as in-person care for weight loss of primary care patients, with either telemedicine or in-person treatment groups achieving equivalent weight loss and more so than the "no treatment" arm. 40 Telemedicine also shows some promise with management of chronic musculoskeletal pain; patients who participate in a 12-month telemedicine intervention with algorithmic guide to pharmacologic management had improved pain scores at one year as compared to usual care. 41 Despite the promise of evidence above, conclusions about telemedicine effectiveness overall can be difficult to determine as the types and intensity of interventions vary drastically from study to study. In the case of asthma care for example, one oft-cited telemedicine study entitled "Telemedicine is as effective as in-person visits for patients with asthma" concludes that children in the telemedicine group and children in an in-person visit group had similar degrees of asthma control over a six-month study period. 42 However, the intervention described in the article is a highly intensive "Remote Presence Solution" involving a digital stethoscope and otoscope and a high-resolution camera situated at the patient's home site. Therefore, broad conclusions about equivalency of care must be interpreted in the context of the intervention being delivered (and whether it is feasible in most practices) as well as the outcome of interest, all of which tend to be quite heterogenous across telemedicine literature. A more recent narrative review on the topic of asthma care via telemedicine that looked at a variety of interventions, ranging from telephoneonly follow ups assessing asthma control to the Remote Presence Solution described above, notes that data remains limited for clinical outcomes on this condition. 43 Additionally, many studies in this review that used a telemedicine intervention combined it with a school-based care Similar challenges on drawing firm conclusions have been noted in a recent umbrella review of systematic reviews regarding telemedicine interventions for diabetes care, cholesterol, and hypertension. 44 Although the authors concluded that telemedicine may improve outcomes for patients with diabetes and there are trends favoring certain subgroups in other conditions, the overall quality of the current evidence is low or very low due to potential bias in study design, heterogeneity in subgroups, imprecision of results or small effect sizes (d/t small sample sizes), publication bias, and underreporting of relevant information such as the treatment of drop-out or missing data. We should look forward to larger, more robust studies that address specific questions on clinical outcomes of telemedicine-supported chronic disease care as pandemic-era data comes to publication.

Utilizing telemedicine for select cases of both acute and chronic disease management will decrease the need for some face-to-face visits. Additionally, there is interest in whether early triage and intervention for patient concerns via telemedicine could decrease face-to-face visits in urgent care and emergency department (ED) settings. A study by Reed and colleagues 36 showed that over a very large sample of appointments (over one million visits for all types of complaints performed via telephone, video, or office visits), short-term hospital and ED utilization did not differ between patients who used telemedicine and patients who scheduled in-person visits. This preliminarily suggests that when patients are free to choose their own mode of care within a clinical context that has consistent physicians and ready follow-up care, telemedicine may be a J o u r n a l P r e -p r o o f reasonable initial alternative to in person care and may not lead to increased emergency care.

Further research in the same setting as the Reed study showed that e-visits for patients who met specific, low-risk criteria for one of five different complaints (e.g. URI, emergency contraception, conjunctivitis, pharyngitis, and urinary tract infections [UTI]) had overall low rates of in-office follow up (about 13.5% of the entire cohort) and less than 1% utilized emergency services. 45 The e-visits took about 2 to 3 minutes of clinician time, suggesting this could be a very cost-effective and efficient intervention for common low-acuity complaints.

Even asynchronous patient-physician communication could be a timely way to reduce the need for more intensive care. Patient access to physician-patient messaging through a secure portal may not decrease face-to-face visits overall, 46,47 but for those with multiple chronic conditions (in this study defined as diabetes plus another chronic condition such as asthma, coronary artery disease, congestive heart failure, or hypertension) it can decrease ED and hospital utilization. 47 This may be particularly significant during times when hospital care is severely overburdened such as flu seasons, pandemics, or natural disasters.

A key health outcome for telemedicine visits which has not been well studied is the diagnostic accuracy of telemedicine evaluation compared with standard care, and the association of delayed diagnosis and adverse health outcomes with each modality. Delayed diagnosis is a frequent allegation in malpractice claims, and to date the medical-legal footprint of telemedicine has been very small. 48 The medical-legal implications of telemedicine are limited at the time of this publication and will certainly be an area of future research.

J o u r n a l P r e -p r o o f As we prepare to enter a future with widespread telemedicine, we must question what will be gained and what may be lost. The benefits of telemedicine after its pandemic renaissance are more apparent now than ever: convenient and timely access to care that overcomes geographic barriers, reduced burden on medical infrastructure (e.g. traffic, facilities wear, perhaps reduced staff needs), and minimal exposure to infectious diseases for all participants. However, concerns still exist that something may be lost if telemedicine becomes more standard practice for all.

Many telehealth authors and enthusiasts assert that telemedicine should play a role as an adjunct rather than a replacement for in-person care. 48 This is certainly the most likely scenario, since pandemic restrictions have lessened at the time of authorship of this manuscript, and it remains unclear whether payment parity and other legislation supporting telemedicine care will remain in long-term effect. Telemedicine is likely to remain pervasive in some fashion, as this author's review of telemedicine both pre-pandemic and during the pandemic shows that it is widely agreeable to those who use it and can it stand alongside standard care for a variety of acute and chronic medical conditions, with the opportunity for more research ready to explore in future.

Going forward, many questions remain ripe for study on what makes for an effective telemedicine encounter. The relative importance of a physical examination in general and for what types of concerns will need to be considered, as well as to what extent patient-provided vital signs and physician-directed virtual examinations can fill this need. Beyond the physical examination, many remain concerned that patient-clinician relationships, rapport, and trust will suffer through the loss of non-verbal communication and therapeutic touch. Technology challenges from all directions including poor reception, blurry screen resolution, or choppy internet connections may further impair the telemedicine rapport. Questions on the impact of telemedicine to specific aspects of the physician-patient relationship deserve further study, as J o u r n a l P r e -p r o o f patient adherence and outcomes are known to be heavily influenced by physician communication techniques. 49 

• Telemedicine use between physicians and patients of all types has greatly expanded with the arrival of the Covid-19 pandemic. It is predicted to remain more prevalent in future United States healthcare.

• Patients who are older, non-white, live in a rural area, or are from a lower socioeconomic group continue to use telemedicine at lower rates. Some of this inequity is due to inconsistent technology access, but more research is needed in this area.

• Telemedicine is generally well-liked by patients who use it, both prior to and during the pandemic.

• Research supports a role for telemedicine in both acute care and chronic disease management and suggests that it is non-inferior to in-person care for health outcomes in certain conditions such as uncomplicated URI, urinary tract infection, low back pain, initial dermatologic concerns (with the help of high-definition photography), and chronic J o u r n a l P r e -p r o o f disease management (with the strongest evidence to date being for diabetes care).

Telemedicine may also decreaseor at least not add toshort-term hospital and emergency department utilization.

• Systems level interventions are needed to solidify telemedicine as a fixture in American healthcare and ensure more equitable access to it, including more universal service and payment parity, expanded broadband and digital technology access to patients and practices, and the allowance of audio-only telemedicine visits as an acceptable alternative to video.

• Clinicians have cited lack of training as a barrier to practicing telemedicine, and more robust training is needed at the undergraduate and graduate medical education levels.

The Association of American Medical Colleges has released telehealth competencies to guide these efforts, and the Society of Teachers of Family Medicine has spearheaded the development of a national telemedicine curriculum.

• Areas of future study should include the development of telemedicine best practices for common acute and chronic conditions and examination of how they affect patientoriented health outcomes, assessment of physician communication techniques that are suited to remote and audio-only care, study of the economic impact of providing telemedicine care either as adjunct to or in place of in-person care, and the provision of telemedicine access to less represented groups. Data from FAIRHealth Monthly Telehealth Regional Tracker. https://www.fairhealth.org/statesby-the-numbers/telehealth. Accessed 12/10/2021. Data from CARES Act AMA Covid-19 Fact Sheet (https://www.ama-assn.org/deliveringcare/public-health/cares-act-ama-covid-19-pandemic-telehealth-fact-sheet) and Medicare Telemedicine Healthcare Provider Fact Sheet (https://www.cms.gov/newsroom/factsheets/medicare-telemedicine-health-care-provider-fact-sheet). Accessed Patients and providers who have a pre-existing relationship No pre-existing relationship will be required

Only at pre-specified sites (ie designated rural areas, certain medical facilities)

Telehealth may originate and be conducted from any site, including patient's home Physicians must conduct telehealth from their place of practice Physicians may conduct telehealth from home Telehealth may not cross state lines Telehealth can now be provided to patient in another state (state-specific restrictions may still apply)

Must be audio-visual (ie video technology) Audio-visual OR audio-only are allowed

Only approved technology platforms Expanded approved platforms including FaceTime, Skype, and Zoom J o u r n a l P r e -p r o o f

Medicare co-insurance and deductibles apply to Telehealth visits Providers may waive cost-sharing for Telehealth paid for by federal programs

Reimbursements for telehealth services is lower than inperson All Telehealth visits, including audio-only, will be reimbursed as if the service was furnished in-person Data from FAIRHealth Monthly Telehealth Regional Tracker. https://www.fairhealth.org/statesby-the-numbers/telehealth. Accessed 12/10/2021.

What Is Telemedicine? A Collection of 104 Peer-Reviewed Perspectives and Theoretical Underpinnings. Telemed E-Health

Opportunities and Barriers for Telemedicine in the U.S. During the COVID-19 Emergency and Beyond

Telehealth Is Here to Stay-In the United States and in Germany. AICGS. Accessed

Telemedicine in the United States: An Introduction for Students and Residents

The Use Of Telemedicine By Physicians: Still The Exception Rather Than The Rule. Health Aff (Millwood)

Hospital Telehealth Adoption Increased in 2014 and 2015 and Was Influenced by Population, Hospital, and Policy Characteristics

Key Factors Affecting the Adoption of Telemedicine by Ambulatory Clinics: Insights from a Statewide Survey

Patients' Satisfaction with and Preference for Telehealth Visits

Telehealth and patient satisfaction: a systematic review and narrative analysis

Patient Satisfaction with Virtual Obstetric Care

Patient and Clinician Experiences With Telehealth for Patient Follow-up Care

Systematic review of patient and caregivers' satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients' health

Telemedicine Evaluations for Low-Acuity Patients Presenting to the Emergency Department: Implications for Safety and Patient Satisfaction

Prevailing Opinions on Connected Health in Austria: Results from an Online Survey

Family Physician and Telehealth: Findings from a National Survy

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic

State of Telemedicine Report: Examining Patient Perspectives and Physician Adoption of Telemedicine Since the COVID-19 Pandemic

Variation In Telemedicine Use And Outpatient Care During The COVID-19 Pandemic In The United States. Health Aff (Millwood)

FAIRHealth Monthly Telehealth Regional Tracker. fairhealth.org. Accessed

Understanding Telemedicine's "New Normal": Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed E-Health

Use Microdata Sample (PUMS) files. State Health Compare, SHADAC, University of Minnesota

Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19

Growth of Ambulatory Virtual Visits and Differential Use by Patient Sociodemographics at One Urban Academic Medical Center During the COVID-19 Pandemic: Retrospective Analysis

Disparities in Telemedicine Access: A Cross-Sectional Study of a Newly Established Infrastructure during the COVID-19 Pandemic

Disparities In Telehealth Use Among California Patients With Limited English Proficiency: Study examines disparities in telehealth use among California patients with limited English proficiency

Research Shows Patients and Clinicians Rated Telemedicine Care Positively During COVID-19 Pandemic -Penn Medicine

Patients Perceptions of Telemedicine Visits Before and After the Coronavirus Disease

Telehealth use and Satisfaction among U.S. Households: Results of a National Survey

The Empirical Foundations of Telemedicine Interventions in Primary Care

Nurse-based telephone protocol versus usual care for management of URI and acute sinusitis: a controlled trial

Clinical outcomes of patients with upper respiratory tract infections and acute sinusitis managed with a Web-based protocol in primary care practice

Access and Quality of Care in Direct-to-Consumer Telemedicine

Patient Satisfaction and Antibiotic Prescribing for Respiratory Infections by Telemedicine

Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits

Treatment and Follow-up Care Associated With Patient-Scheduled Primary Care Telemedicine and In-Person Visits in a Large Integrated Health System

Telemedicine in dermatology: findings and experiences worldwide -a systematic literature review

Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review

Clinical pharmacy specialists providing consistent comprehensive medication management with increased efficiency through telemedicine during the COVID19 pandemic

Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice

Telecare Collaborative Management of Chronic Pain in Primary Care: A Randomized Clinical Trial

Telemedicine is as effective as in-person visits for patients with asthma

Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post-COVID-19 era

Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses

Patient e-Visit Use and Outcomes for Common Symptoms in an Integrated Health Care Delivery System

Impact of Patient Portal Secure Messages and Electronic Visits on Adult Primary Care Office Visits

Patients with complex chronic conditions: Health care use and clinical events associated with access to a patient portal

Your Patient Is Logging On Now: The Risks and Benefits of Telehealth in the Future of Healthcare. The Doctors Company TDC Group

Effective physician-patient communication and health outcomes: a review